About
HarborSite develops engineered site-specific recombinase enzymes that enable precise and efficient therapeutic gene insertions into safe genomic locations to provide potential one-time treatments for genetic and age-related diseases.
Explore HarborSite's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.